Patent Cliff Risk
102 articles in this topicContinuing coverage of patent cliff risk and what it means for the sector, patients and investors.
-
Aug 16 · 13:11Bio Business News
Why Patent Cliff Risk Is Attracting Big Pharma Attention
-
Aug 11 · 14:53Bio Business News
How Patent Cliff Risk Is Reshaping Biotech M&A Activity
-
Aug 10 · 10:09Bio Business News
Why Patent Cliff Risk Is Attracting Big Pharma Attention Like Never Before
-
Aug 9 · 23:36Bio Business News
Why Patent Cliff Risk Is Reshaping How Biotech Investors Build Their Portfolios
-
Aug 9 · 10:09Bio Business News
Why Patent Cliff Risk Is Attracting Big Pharma Attention Like Never Before
-
Aug 6 · 17:41Bio Business News
How Patent Cliff Risk Is Reshaping Biotech M&A Activity
-
Aug 5 · 16:07Bio Business News
How Patent Cliff Risk Is Reshaping Biotech M&A Activity
-
Aug 5 · 14:32Bio Business News
The Business Case for Biotech Investors Navigating Patent Cliff Risk
-
Aug 5 · 11:43Bio Business News
How Patent Cliff Risk Is Reshaping Biotech M&A Activity
-
Aug 4 · 22:14Bio Business News
The Business Case for Biotech Investors Navigating Patent Cliff Risk
-
Aug 3 · 17:39Bio Business News
How Patent Cliff Risk Is Reshaping Biotech M&A Activity
-
Aug 1 · 23:36Bio Business News
How Patent Cliff Risk Is Reshaping Biotech M&A Activity
-
Aug 1 · 16:22Bio Business News
The Case For Taking Patent Cliff Risk More Seriously Than Ever
-
Aug 1 · 10:07Bio Business News
The Patent Cliff Risk That Has Big Pharma Scrambling for Solutions
-
Jul 30 · 22:13Bio Business News
How Patent Cliff Risk Is Reshaping Biotech M&A Activity
-
Jul 30 · 19:06Bio Business News
The Business Case for Biotech Investors Who Understand Patent Cliff Risk
-
Jul 30 · 10:13Bio Business News
The Signal Investors Are Watching in Pharma Deal Flow Right Now
-
Jul 29 · 22:09Bio Business News
How Patent Cliff Risk Is Reshaping Biotech M&A Activity
-
Jul 29 · 19:18Bio Business News
The Hidden Force Reshaping Pharma Investment: Understanding Patent Cliff Risk
-
Jul 29 · 10:11Bio Business News
Behind the Dealmaking Surge: How Patent Cliff Risk Is Reshaping Biotech M&A Activity
-
Jul 28 · 14:32Bio Business News
The Hidden Threat Inside Pharma Portfolios That Investors Can No Longer Ignore
-
Jul 26 · 19:18Bio Business News
Inside the Patent Cliff Risk That Is Quietly Reshaping Pharmaceutical Investment
-
Jul 26 · 14:32Bio Business News
The Patent Cliff Risk Reshaping Big Pharma's Growth Strategy
-
Jul 25 · 13:16Bio Business News
The Hidden Threat Reshaping Pharma Portfolios as Patent Cliff Risk Intensifies